CIK 0001856725
- Emerging growth company
Rani Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- RANI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 863114789
- Phone
- +1 408-457-3700
- Business address
- 47709 FREMONT BLVD, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-22 | Groen Eric General Counsel | Grant or award · Stock Option (Right to Buy) | +74,400 | 74,400 | ||
| 2022-03-07 | Farquharson Andrew Director | Conversion | −2,309,490 | 256,623 | ||
| 2022-03-07 | Farquharson Andrew Director | Conversion | +2,309,490 | 2,375,617 | ||
| 2022-03-07 | Farquharson Andrew Director | Other disposition | −2,229,238 | 146,379 | ||
| 2022-03-07 | Farquharson Andrew Director | Conversion · Class A Common LLC Units | −2,309,490 | 256,623 | ||
| 2022-03-07 | IMRAN MIR A Director | Conversion | −2,309,490 | 22,667,747 | ||
| 2022-03-07 | IMRAN MIR A Director | Conversion | +2,309,490 | 2,377,197 | ||
| 2022-03-07 | IMRAN MIR A Director | Other disposition | −2,229,238 | 147,959 | ||
| 2022-03-07 | IMRAN MIR A Director | Conversion · Class A Common LLC Units | −2,309,490 | 22,667,747 | ||
| 2022-02-03 | Imran Talat Chief Executive Officer | Other disposition | −827,467 | 0 | ||
| 2022-02-03 | Imran Talat Chief Executive Officer | Other acquisition | +12,343 | 12,343 | ||
| 2022-02-03 | IMRAN MIR A Director | Other disposition | −827,467 | 0 | ||
| 2022-02-03 | IMRAN MIR A Director | Other acquisition | +67,707 | 67,707 | ||
| 2022-02-03 | Nanavaty Maulik Director | Other acquisition | +11,017 | 11,017 | ||
| 2022-02-03 | Farquharson Andrew Director | Other disposition | −827,467 | 0 | ||
| 2022-02-03 | Farquharson Andrew Director | Other acquisition | +66,127 | 66,127 | ||
| 2022-02-03 | InCube Labs, L.L.C. 10% owner | Other acquisition | +13,923 | 13,923 | ||
| 2022-01-03 | Rometty Lisa Ann Director | Grant or award · Stock Option (Right to Buy) | +49,037 | 49,037 | ||
| 2021-11-10 | Baranowski Lyn Director | Grant or award · Stock Option (Right to Buy) | +31,695 | 31,695 | ||
| 2021-09-09 | Sanford Svai S Chief Financial Officer | Grant or award | +106,200 | 106,200 |
Page 14 of 15 · 285 trades